Karuna Therapeutics, Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d0685770-909d-4282-a0c4-950d7f434581/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-433.7M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-018395 |
| FY 2022 | $-276.3M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-003929 |
| FY 2021 | $-143.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001855 |
| FY 2020 | $-68.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008416 |
| FY 2019 | $-44.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-012311 |
| FY 2018 | $-17.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-012311 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Karuna Therapeutics, Inc. — all facts · Revenue · Operating Income